In my continuing quest to provide information on affordable treatment programs for people living with addictions, I bring you part 2 of the clinical trial info.
Community Reinforcement and Family Training for Drug Abuse Treatment Retention/HIV Risk Reduction
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy201768.aspx
The planned research will adapt an intervention of known efficacy to target a new outcome of significant importance to public health. Specifically the Community Reinforcement and Family Training (CRAFT) procedures will be adapted, from reinforcing treatment entry, to reinforcing treatment retention and HIV risk behavior reduction in persons with opioid dependence who receive a Buprenorphine taper detoxification. The research plan includes three phases: 1) development of a manual guided therapy, 2) development of therapist training and fidelity measures and 3) a randomized pilot evaluation with 52 patients receiving either the new CRAFT treatment or treatment as usual.
Maryhaven
Columbus, OH 43207
United States
Primary Contact:
Gregory S Brigham, Ph.D.
Email: Gbrigham@maryhaven.com
Phone: 614-324-5417
A Laboratory Model for Heroin Abuse Medications
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy111020.aspx
The purpose of this study is to evaluate the effects of treatment medications (methadone, buprenorphine, LAAM, naltrexone, naltrexone microcapsules, and methoclocinnamox) on I.V. and smoked heroin self-administration."
Columbia University
New York, NY 10032
United States
Primary Contact:
Sandra D Comer, Ph.D.
Email: sdc10@columbia.edu
Phone: 212-543-5981
.tiny.jpg "small")
